The Verdict on CBD Is … Confusing/WSJ June 6, 2019June 6, 2019 / broadcasthealthandmedicalnews Spencer Jakab “An FDA hearing on CBD, the nonpsychoactive substance in marijuana, sent industry shares down sharply, but not for long” Read more Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related
THN 